FBXO32 and dilated cardiomyopathy: The aim of the study was to clarify if an upstream pathway that regulates the expression of MAFbx and MuRF1 is changed in dilated cardiomyopathy of ischemic (IDCM) and non-ischemic origin (NIDCM).